Literature DB >> 1915518

Defective activation of the alternative pathway of complement in patients with homozygous C2 deficiency: studies in two unrelated families.

R Schwertz1, E Esser, R A Seger, A Rubinstein, G Hauptmann, V Wahn.   

Abstract

Selective homozygous deficiency of the second component of complement, C2, with increased susceptibility to infection was detected in five children of two unrelated families. Because the haemolytic activity of the alternative complement pathway (AP) was in the low normal range, we evaluated the AP activation pattern. Serum levels of factor B measured immunochemically and the haemolytic function of factor B were low normal. Levels of C3d were not increased. Activation products of factor B were undetectable indicating the absence of in vivo activation of AP. Activation of C3 in vitro by activators of the AP (zymosan A and lipopolysaccharide) was profoundly deficient in homozygous C2 deficiency while heterozygous carriers exhibited intermediate values. There was no correlation between serum levels of factor B and in vitro C3 activation. We conclude that defective AP activation may contribute to increased susceptibility to bacterial infections in some patients with homozygous C2 deficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915518     DOI: 10.1007/bf02072626

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.

Authors:  M Brai; G Misiano; S Maringhini; I Cutaja; G Hauptmann
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

2.  Hereditary deficiency of the second component of complement (C'2) in man.

Authors:  M R Klemperer; H C Woodworth; F S Rosen; K F Austen
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Phagocytosis of microorganisms.

Authors:  M A Horwitz
Journal:  Rev Infect Dis       Date:  1982 Jan-Feb

5.  The molecular basis for genetic deficiency of the second component of human complement.

Authors:  F S Cole; A S Whitehead; H S Auerbach; T Lint; H J Zeitz; P Kilbridge; H R Colten
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

6.  The alternative pathway C3/C5 convertase: chemical basis of factor B activation.

Authors:  P H Lesavre; T E Hugli; A F Esser; H J Müller-Eberhard
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

7.  Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian family.

Authors:  J M Delâge; P Bergeron; J Simard; G Lehner-Netsch; E Prochazka
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

8.  Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.

Authors:  O Meyer; G Hauptmann; G Tappeiner; H D Ochs; F Mascart-Lemone
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

9.  Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia.

Authors:  E W Gelfand; C P Rao; J O Minta; T Ham; D B Purkall; S Ruddy
Journal:  Am J Med       Date:  1987-03-23       Impact factor: 4.965

10.  HLA antigen studies in a family with C2 deficiency.

Authors:  G Opelz; M M Glovsky
Journal:  J Immunogenet       Date:  1976-10
View more
  2 in total

Review 1.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Molecular heterogeneity in deficiency of complement protein C2 type I.

Authors:  X Wang; A Circolo; M L Lokki; P G Shackelford; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.